Description
B4GALT1 Polyclonal Antibody (CAB21847)
The B4GALT1 Polyclonal Antibody (CAB21847) is a high-quality antibody developed for reliable detection and analysis of target proteins. This antibody, generated in rabbits, exhibits high reactivity with human samples and is specifically validated for use in Western blot applications. By binding to the B4GALT1 protein, this antibody enables precise detection and analysis in a variety of cell types, making it an essential tool for investigations in glycobiology and related fields.B4GALT1 plays a crucial role in protein glycosylation, a post-translational modification that influences protein function and stability. Dysregulation of this enzyme has been linked to various diseases, including cancer and genetic disorders.
This antibody is validated for use in WB, ELISA applications and has demonstrated reactivity against Human samples.
| Product Name: | B4GALT1 Polyclonal Antibody |
| SKU: | CAB21847 |
| Size: | 20μL, 100μL |
| Reactivity: | Human |
| Conjugate: | Unconjugated |
| Immunogen: | Recombinant protein (or fragment).This information is considered to be commercially sensitive. | ||||
| Sequence: | LPQL VGVS TPLQ GGSN SAAA IGQS SGEL RTGG ARPP PPLG ASSQ PRPG GDSS PVVD SGPG PASN LTSV PVPH TTAL SLPA CPEE SPLL VGPM LIEF NMPV DLEL VAKQ NPNV KMGG RYAP RDCV SPHK VAII IPFR NRQE HLKY WLYY LHPV LQRQ QLDY GIYV IN | ||||
| Tested Applications: | WB ELISA | ||||
| Recommended Dilution: |
| ||||
| Synonyms: | GT1, GTB, CDG2D, GGTB2, B4GAL-T1, beta4Gal-T1, B4GALT1 |
| Positive Sample: | L-O2, HeLa, 22Rv1 |
| Cellular Localization: | Cell Membrane, Cell Projection, Cell Surface, Golgi Apparatus, Golgi Stack Membrane, Secreted, Single-Pass Type Ii Membrane Protein, Filopodium. |
| Calculated MW: | 44kDa |
| Observed MW: | Refertofigures |
This gene is one of seven beta-1,4-galactosyltransferase (beta4GalT) genes. They encode type II membrane-bound glycoproteins that appear to have exclusive specificity for the donor substrate UDP-galactose; all transfer galactose in a beta1,4 linkage to similar acceptor sugars: GlcNAc, Glc, and Xyl. Each beta4GalT has a distinct function in the biosynthesis of different glycoconjugates and saccharide structures. As type II membrane proteins, they have an N-terminal hydrophobic signal sequence that directs the protein to the Golgi apparatus and which then remains uncleaved to function as a transmembrane anchor. By sequence similarity, the beta4GalTs form four groups: beta4GalT1 and beta4GalT2, beta4GalT3 and beta4GalT4, beta4GalT5 and beta4GalT6, and beta4GalT7. This gene is unique among the beta4GalT genes because it encodes an enzyme that participates both in glycoconjugate and lactose biosynthesis. For the first activity, the enzyme adds galactose to N-acetylglucosamine residues that are either monosaccharides or the nonreducing ends of glycoprotein carbohydrate chains. The second activity is restricted to lactating mammary tissues where the enzyme forms a heterodimer with alpha-lactalbumin to catalyze UDP-galactose + D-glucose <=> UDP + lactose. The two enzymatic forms result from alternate transcription initiation sites and post-translational processing. Two transcripts, which differ only at the 5' end, with approximate lengths of 4.1 kb and 3.9 kb encode the same protein. The longer transcript encodes the type II membrane-bound, trans-Golgi resident protein involved in glycoconjugate biosynthesis. The shorter transcript encodes a protein which is cleaved to form the soluble lactose synthase.
| Purification Method | Affinity purification |
| Gene ID | 2683 |
| Buffer Information | Store at -20℃. Avoid freeze / thaw cycles. Buffer: PBS containing 50% glycerol, preserved with proclin300 or sodium azide, pH 7.3. |
